Olopatadine Nasal Spray 0.6% is Superior to Vehicle and Non-Inferior to Azelastine Nasal Spray 0.1% When Dosed Twice-Daily for the Treatment of Seasonal Allergic Rhinitis

Authors :: Margaret Drake
S. Shah
G.M. Wall
Dale Mohar
Paul H. Ratner
K. Crenshaw
Source :: Journal of Allergy and Clinical Immunology. 121:S49-S49
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: medicine.medical_specialty
Nasal spray
business.industry
medicine.medical_treatment
Immunology
Immunology and Allergy
Medicine
Olopatadine
business
Azelastine
Dermatology
medicine.drug

Tools